JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Normal, non-disease
Established from primary cultures of type 1 astrocytes from brain frontal cortex tissue of 1 day old rats. The cultures were transfected 3 days after initial plating with a DNA construct containing the oncogenic early region of SV40 under the transcriptional control of the human GFAP promoter (pGFA-SV-Tt) and pPGK-neo which contains the murine phosphoglycerate kinase gene promoter. The transfectants were selected with G418 and cloned.
Rattus norvegicus, rat Tissue: Brain, cortex Morphology:Fibroblast Properties: Adherent, astrocyte, type 1 phenotype Uses:The cells were not tumorigenic in immunosuppressed mice, but they formed colonies in semisolid medium. About 20% of the cells have glial fibrillary acidic protein (GFAP) immunoreactivity. The cells have a high affinity uptake mechanism for gamma aminobutyric acid (GABA) that is inhibitable by beta alanine. The cells produce alpha 2 macroglobulin in amounts similar to those found in primary astrocytes but produce transferrin in much lesser amounts. This line does not produce proenkephalin A, does not express the O4 or A2B5 epitopes characteristic of type 2 astrocytes, and does not express galactocerebroside. SV40 T-antigen was found in the nuclei of over 95% of the cells examined by immunostaining. Patient: Neonate, Sprague-Dawley rat Medium: DMEM Medium + 10% FBS Subculture:1:2 to 1:9 using 0.25% trypsin or trypsin/EDTA. Change medium every 2-3 days. Culture at 5% CO2; 37C. Freezing Medium:Complete culture medium supplemented with 10% (v/v) DMSO Biosafety Level: II Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative
Brain, cortex Morphology:Fibroblast Properties: Adherent, astrocyte, type 1 phenotype Uses:The cells were not tumorigenic in immunosuppressed mice, but they formed colonies in semisolid medium. About 20% of the cells have glial fibrillary acidic protein (GFAP) immunoreactivity. The cells have a high affinity uptake mechanism for gamma aminobutyric acid (GABA) that is inhibitable by beta alanine. The cells produce alpha 2 macroglobulin in amounts similar to those found in primary astrocytes but produce transferrin in much lesser amounts. This line does not produce proenkephalin A, does not express the O4 or A2B5 epitopes characteristic of type 2 astrocytes, and does not express galactocerebroside. SV40 T-antigen was found in the nuclei of over 95% of the cells examined by immunostaining. Patient: Neonate, Sprague-Dawley rat Medium: DMEM Medium + 10% FBS Subculture:1:2 to 1:9 using 0.25% trypsin or trypsin/EDTA. Change medium every 2-3 days. Culture at 5% CO2; 37C. Freezing Medium:Complete culture medium supplemented with 10% (v/v) DMSO Biosafety Level: II Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative
Fibroblast Properties: Adherent, astrocyte, type 1 phenotype Uses:The cells were not tumorigenic in immunosuppressed mice, but they formed colonies in semisolid medium. About 20% of the cells have glial fibrillary acidic protein (GFAP) immunoreactivity. The cells have a high affinity uptake mechanism for gamma aminobutyric acid (GABA) that is inhibitable by beta alanine. The cells produce alpha 2 macroglobulin in amounts similar to those found in primary astrocytes but produce transferrin in much lesser amounts. This line does not produce proenkephalin A, does not express the O4 or A2B5 epitopes characteristic of type 2 astrocytes, and does not express galactocerebroside. SV40 T-antigen was found in the nuclei of over 95% of the cells examined by immunostaining. Patient: Neonate, Sprague-Dawley rat Medium: DMEM Medium + 10% FBS Subculture:1:2 to 1:9 using 0.25% trypsin or trypsin/EDTA. Change medium every 2-3 days. Culture at 5% CO2; 37C. Freezing Medium:Complete culture medium supplemented with 10% (v/v) DMSO Biosafety Level: II Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative
Adherent, astrocyte, type 1 phenotype Uses:The cells were not tumorigenic in immunosuppressed mice, but they formed colonies in semisolid medium. About 20% of the cells have glial fibrillary acidic protein (GFAP) immunoreactivity. The cells have a high affinity uptake mechanism for gamma aminobutyric acid (GABA) that is inhibitable by beta alanine. The cells produce alpha 2 macroglobulin in amounts similar to those found in primary astrocytes but produce transferrin in much lesser amounts. This line does not produce proenkephalin A, does not express the O4 or A2B5 epitopes characteristic of type 2 astrocytes, and does not express galactocerebroside. SV40 T-antigen was found in the nuclei of over 95% of the cells examined by immunostaining. Patient: Neonate, Sprague-Dawley rat Medium: DMEM Medium + 10% FBS Subculture:1:2 to 1:9 using 0.25% trypsin or trypsin/EDTA. Change medium every 2-3 days. Culture at 5% CO2; 37C. Freezing Medium:Complete culture medium supplemented with 10% (v/v) DMSO Biosafety Level: II Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative
The cells were not tumorigenic in immunosuppressed mice, but they formed colonies in semisolid medium. About 20% of the cells have glial fibrillary acidic protein (GFAP) immunoreactivity. The cells have a high affinity uptake mechanism for gamma aminobutyric acid (GABA) that is inhibitable by beta alanine. The cells produce alpha 2 macroglobulin in amounts similar to those found in primary astrocytes but produce transferrin in much lesser amounts. This line does not produce proenkephalin A, does not express the O4 or A2B5 epitopes characteristic of type 2 astrocytes, and does not express galactocerebroside. SV40 T-antigen was found in the nuclei of over 95% of the cells examined by immunostaining. Patient: Neonate, Sprague-Dawley rat Medium: DMEM Medium + 10% FBS Subculture:1:2 to 1:9 using 0.25% trypsin or trypsin/EDTA. Change medium every 2-3 days. Culture at 5% CO2; 37C. Freezing Medium:Complete culture medium supplemented with 10% (v/v) DMSO Biosafety Level: II Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative
Neonate, Sprague-Dawley rat Medium: DMEM Medium + 10% FBS Subculture:1:2 to 1:9 using 0.25% trypsin or trypsin/EDTA. Change medium every 2-3 days. Culture at 5% CO2; 37C. Freezing Medium:Complete culture medium supplemented with 10% (v/v) DMSO Biosafety Level: II Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative
DMEM Medium + 10% FBS Subculture:1:2 to 1:9 using 0.25% trypsin or trypsin/EDTA. Change medium every 2-3 days. Culture at 5% CO2; 37C. Freezing Medium:Complete culture medium supplemented with 10% (v/v) DMSO Biosafety Level: II Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative
1:2 to 1:9 using 0.25% trypsin or trypsin/EDTA. Change medium every 2-3 days. Culture at 5% CO2; 37C. Freezing Medium:Complete culture medium supplemented with 10% (v/v) DMSO Biosafety Level: II Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative
Complete culture medium supplemented with 10% (v/v) DMSO
II Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative
Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative
Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative
Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative
HIV: Negative Hepatitis B: Negative Hepatitis C: Negative
Hepatitis B: Negative Hepatitis C: Negative
Hepatitis C: Negative
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!